PECAM1 and neoplasm: Additional characterization of tumor markers for BLT-derived GBM8 and GBM18 was performed, including SOX2 (Supplementary Figures 2B, C), CD31 (Supplementary Figures 2D, E), and Ki67 (Supplementary Figures 2F, G).